Zacks.com on MSN2d
Roche Antiviral Drug Reduces Transmission in Late-stage StudyRoche RHHBY announced positive top-line results from a late-study on influenza drug, Xofluza. The CENTERSTONE study was a global phase III trial investigating the efficacy of single-dose Xofluza, ...
It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...
Oseltamivir (Tamiflu®) prescribing patterns have improved among infants over time; however, targeted provider education may help further improve prescribing practices.
We’re still asking people with COVID to jump through far too many hoops to get their hands on Pfizer Inc.’s Paxlovid.
Oseltamivir (as phospate) 6mg/mL; pwd for reconstitution; tutti-frutti flavor; contains sorbitol. Not a substitute for annual influenza vaccination. Consider available information on influenza ...
Infectious disease expert Dr. William Schaffner says because of COVID fatigue, people are underestimating the dangers of both ...
Sanofi has made a bold play to bolster its consumer health business, licensing non-prescription rights to Roche’s influenza drug Tamiflu – even though there’s no guarantee it will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback